If it's part of your DNA, is it something that you can change? For the longest time the answer to that question has been no, but now that's not necessarily the case. Genetics is a world that is evolving at a rapid pace. And with a lot of new data coming out in the field, there is a growing need to sort that data and make it actionable. That's what this week's guest is doing. Genomenon is a genomic health IT company that connects genomic data with patient DNA in order to help diagnose and treat those with rare genetic cancers and diseases. They do this by providing their customers with tools to solve previously unsolvable mysteries. We sat down with Mike Klien, the CEO of Genomenon to explore the impact that their work is having on the health industry, and within the genetics market.
Clara is the Content Specialist at BCC Research, where she spends her time writing blogs and white papers, designing graphics and thinking up ways BCC can take over the world...like with a podcast.
A world traveler (less so during COVID19, of course), marketing whiz and always thirsty for knowledge, Clara finds innovators in a variety of fields and asks the question that our listeners want to know: How will this industry, technology or company shape how we live and work in the future?